Business ❯Pharmaceutical Industry ❯Company Performance

Stock Market

Alnylam Pharmaceuticals Investor Reactions

Novo Nordisk's Obesity Pill Shows Modest Results, Stocks Drop

Alnylam's Vutrisiran Shows Mixed Results in Cardiomyopathy Study